Clinical trial
Pharmacogenomics to Predict Responses to SGLT2 Inhibitors
NCT02891954 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacogenomics to Predict Responses to SGLT2 Inhibitors
- Lead sponsor
- University of Maryland, Baltimore
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- September 30, 2016
- Completion date
- December 25, 2026
- Enrollment
- 700 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.